Radar > 394600

CVC, Cinven, KKR, and Permira bid to acquire CDMO business of Laboratorios Rovi, valued at around EUR 3.5bn

CVC, Cinven, KKR y Permira pujan por adquirir negocio CDMO de Laboratorios Rovi, valorado en alrededor de EUR 3.500m

Intel ID : 394600

Relevant Documents

Bidder

Cinven
United Kingdom
KKR
United States
Permira
United Kingdom

Target

Laboratorios Rovi
Spain

Advisors

prospect

Intel ID 394600
Value EUR 3.500,00m (Approx.)
Native Currency Euro (EUR)
Financial Data - Laboratorios Rovi
(31 Dec 2023)
Revenue: -
EBITDA: -
Net Debt: -
Date
Country
Geography
Subsector (Old TTR Sectors)
Primary Subsector (TTRSC)
25.01.09 Private Equity (Primary)
25 Financial Services / 25.01 Banking & Investment

30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary)
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Type
Intel Grade
Source
Tags

Bidder

Name
potential
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Bidder

Name
potential
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Bidder

Name
potential
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Bidder

Name
potential
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Target

Name
potential
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Country
Website
Description

Financial Advisory

Radar

Date Title Type Intel Grade Country Subsector  

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.